Titre : | Practical considerations for the clinical use of buprenorphine (2004) |
Auteurs : | H. E. JONES |
Type de document : | Article : Périodique |
Dans : | Science and Practice Perspectives (Vol.2, n°2, August 2004) |
Article en page(s) : | 4-19 |
Note générale : | Science and Practice Perspectives, 2004, 2, (2), 4-19 |
Langues: | Anglais |
Discipline : | TRA (Traitement et prise en charge / Treatment and care) |
Mots-clés : |
Thésaurus mots-clés BUPRENORPHINE ; MECANISME D'ACTION ; METHADONE ; ALCOOL ; POLYCONSOMMATION ; MESURES QUANTITATIVES ; EFFICACITE |
Résumé : | Buprenorphine is a new and attractive medication option for many opioid-addicted adults and their physicians. Before initiating buprenorphine treatment, providers must be aware of such critical factors as how the medication works, its efficacy and safety profile, how it is used in opioid withdrawal as well as maintenance treatment, and how patients can best be selected, educated about buprenorphine, and monitored throughout treatment. This article reviews these important issues as well as requirements for physician and staff training and needs for additional research on this unique medication. |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 138 |
Affiliation : | Etats-Unis. United States. |
Centre Emetteur : | 13 OFDT |
Cote : | R00144 |
Lien : | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2851017/?report=abstract |
Accueil